scholarly journals Corrigendum To: Allantoin Increases Cadmium Tolerance in Arabidopsis via Activation of Antioxidant Mechanisms

Author(s):  
Maryam Nourimand ◽  
Christopher D Todd
2016 ◽  
Vol 57 (12) ◽  
pp. 2485-2496 ◽  
Author(s):  
Maryam Nourimand ◽  
Christopher D. Todd

Molecules ◽  
2021 ◽  
Vol 26 (10) ◽  
pp. 2930
Author(s):  
Jelena Šuran ◽  
Ivica Cepanec ◽  
Tomislav Mašek ◽  
Božo Radić ◽  
Saša Radić ◽  
...  

Propolis is a honeybee product known for its antioxidant, anti-inflammatory, anticancer, and antimicrobial effects. It is rich in bioactive molecules whose content varies depending on the botanical and geographical origin of propolis. These bioactive molecules have been studied individually and as a part of propolis extracts, as they can be used as representative markers for propolis standardization. Here, we compare the pharmacological effects of representative polyphenols and whole propolis extracts. Based on the literature data, polyphenols and extracts act by suppressing similar targets, from pro-inflammatory TNF/NF-κB to the pro-proliferative MAPK/ERK pathway. In addition, they activate similar antioxidant mechanisms of action, like Nrf2-ARE intracellular antioxidant pathway, and they all have antimicrobial activity. These similarities do not imply that we should attribute the action of propolis solely to the most representative compounds. Moreover, its pharmacological effects will depend on the efficacy of these compounds’ extraction. Thus, we also give an overview of different propolis extraction technologies, from traditional to modern ones, which are environmentally friendlier. These technologies belong to an open research area that needs further effective solutions in terms of well-standardized liquid and solid extracts, which would be reliable in their pharmacological effects, environmentally friendly, and sustainable for production.


2021 ◽  
Vol 284 ◽  
pp. 117123
Author(s):  
Xinghao Yang ◽  
Lingshuai Kong ◽  
Yueqiao Wang ◽  
Jiuchang Su ◽  
Wenbiao Shen

1994 ◽  
Vol 269 (20) ◽  
pp. 14690-14697
Author(s):  
J.A. Wemmie ◽  
A.L. Wu ◽  
K.D. Harshman ◽  
C.S. Parker ◽  
W.S. Moye-Rowley

2021 ◽  
pp. 1-11
Author(s):  
Iris Cristina Maia Oliveira ◽  
Auriana Serra Vasconcelos Mallmann ◽  
Francisco Adelvane de Paula Rodrigues ◽  
Laura Maria Teodorio Vidal ◽  
Iardja Stéfane Lopes Sales ◽  
...  

<b><i>Background:</i></b> Depression is a common, chronic, and often recurrent serious mood disorder. Conventional antidepressants present limitations that stimulate the search for new drugs. Antioxidant and neuroprotective substances are potential antidepressant agents. In this context, riparin I (RIP I) has presented promising results, emerging as a potential source of a new therapeutic drug. In this study, the antidepressant effect of RIP I was evaluated in an animal model of depression induced by corticosterone (CORT). The involvement of neuroprotective and antioxidant mechanisms in the generation of this effect was also assessed. <b><i>Methods:</i></b> Female mice were submitted to CORT for 21 days and treated with RIP I in the last 7 days. Behavioral and neurochemical analyses were performed. <b><i>Results:</i></b> The administration of RIP I reversed the depressive and psychotic-like behavior, as well as the cognitive impairment caused by CORT, in addition to regulating oxidative stress parameters and BDNF levels in depression-related brain areas. <b><i>Conclusion:</i></b> These findings suggest that RIP I can be a strong candidate for drugs in the treatment of depression.


2011 ◽  
Vol 32 (6) ◽  
pp. 888-896 ◽  
Author(s):  
Anupam Bishayee ◽  
Deepak Bhatia ◽  
Roslin J. Thoppil ◽  
Altaf S. Darvesh ◽  
Eviatar Nevo ◽  
...  

2013 ◽  
Vol 3 (2) ◽  
pp. 152-155 ◽  
Author(s):  
V. E. Tsyganov ◽  
O. A. Kulaeva ◽  
M. R. Knox ◽  
A. Yu. Borisov ◽  
I. A. Tikhonovich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document